These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 24909811

  • 1. Glucagon-like peptide-1 analog-mediated protection against cholesterol-induced apoptosis via mammalian target of rapamycin activation in pancreatic βTC-6 cells -1mTORβTC-6.
    Zhou J, Wu J, Zheng F, Jin M, Li H.
    J Diabetes; 2015 Mar; 7(2):231-9. PubMed ID: 24909811
    [Abstract] [Full Text] [Related]

  • 2. The human glucagon-like peptide-1 analogue liraglutide regulates pancreatic beta-cell proliferation and apoptosis via an AMPK/mTOR/P70S6K signaling pathway.
    Miao XY, Gu ZY, Liu P, Hu Y, Li L, Gong YP, Shu H, Liu Y, Li CL.
    Peptides; 2013 Jan; 39():71-9. PubMed ID: 23116613
    [Abstract] [Full Text] [Related]

  • 3. Activation of glucagon-like peptide-1 receptor inhibits growth and promotes apoptosis of human pancreatic cancer cells in a cAMP-dependent manner.
    Zhao H, Wei R, Wang L, Tian Q, Tao M, Ke J, Liu Y, Hou W, Zhang L, Yang J, Hong T.
    Am J Physiol Endocrinol Metab; 2014 Jun 15; 306(12):E1431-41. PubMed ID: 24801389
    [Abstract] [Full Text] [Related]

  • 4. Liraglutide, a human glucagon-like peptide-1 analogue, stimulates AKT-dependent survival signalling and inhibits pancreatic β-cell apoptosis.
    Kapodistria K, Tsilibary EP, Kotsopoulou E, Moustardas P, Kitsiou P.
    J Cell Mol Med; 2018 Jun 15; 22(6):2970-2980. PubMed ID: 29524296
    [Abstract] [Full Text] [Related]

  • 5. Paradoxical effect of rapamycin on inflammatory stress-induced insulin resistance in vitro and in vivo.
    Yang P, Zhao Y, Zhao L, Yuan J, Chen Y, Varghese Z, Moorhead JF, Chen Y, Ruan XZ.
    Sci Rep; 2015 Oct 09; 5():14959. PubMed ID: 26449763
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Rapamycin protects against dominant negative-HNF1A-induced apoptosis in INS-1 cells.
    Farrelly AM, Kilbride SM, Bonner C, Prehn JH, Byrne MM.
    Apoptosis; 2011 Nov 09; 16(11):1128-37. PubMed ID: 21874357
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A study on the mechanism of rapamycin mediating the sensitivity of pancreatic cancer cells to cisplatin through PI3K/AKT/mTOR signaling pathway.
    Li B, Yang J, Lu Z, Liu B, Liu F.
    J BUON; 2019 Nov 09; 24(2):739-745. PubMed ID: 31128031
    [Abstract] [Full Text] [Related]

  • 11. Suppression of AKT phosphorylation restores rapamycin-based synthetic lethality in SMAD4-defective pancreatic cancer cells.
    Le Gendre O, Sookdeo A, Duliepre SA, Utter M, Frias M, Foster DA.
    Mol Cancer Res; 2013 May 09; 11(5):474-81. PubMed ID: 23443316
    [Abstract] [Full Text] [Related]

  • 12. Protection of pancreatic β-cells against glucotoxicity by short-term treatment with GLP-1.
    Park SH, Park JH, Shim HM, Na AY, Bae KC, Lim JG, Song DK.
    Biochem Biophys Res Commun; 2015 Apr 17; 459(4):561-7. PubMed ID: 25757909
    [Abstract] [Full Text] [Related]

  • 13. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
    Lin CY, Hsu SC, Lee HS, Lin SH, Tsai CS, Huang SM, Shih CC, Hsu YJ.
    J Vasc Surg; 2013 Feb 17; 57(2):475-85. PubMed ID: 23265586
    [Abstract] [Full Text] [Related]

  • 14. Activation of glucagon-like peptide-1 receptor inhibits tumourigenicity and metastasis of human pancreatic cancer cells via PI3K/Akt pathway.
    Zhao H, Wang L, Wei R, Xiu D, Tao M, Ke J, Liu Y, Yang J, Hong T.
    Diabetes Obes Metab; 2014 Sep 17; 16(9):850-60. PubMed ID: 24641303
    [Abstract] [Full Text] [Related]

  • 15. Liraglutide Improves Endothelial Function via the mTOR Signaling Pathway.
    Wu H, Xiao C, Zhao Y, Yin H, Yu M.
    J Diabetes Res; 2021 Sep 17; 2021():2936667. PubMed ID: 34447854
    [Abstract] [Full Text] [Related]

  • 16. [Effects of glucagon-like peptide-1 on the free fatty acid-induced expression of pancreatic derived factor in cultured β-TC3 cell line].
    Chen S, Cao XP, Xiao HP, Li YB.
    Zhonghua Yi Xue Za Zhi; 2011 May 31; 91(20):1413-6. PubMed ID: 21756815
    [Abstract] [Full Text] [Related]

  • 17. Exogenous supplement of glucagon like peptide-1 protects the heart against aortic banding induced myocardial fibrosis and dysfunction through inhibiting mTOR/p70S6K signaling and promoting autophagy.
    Zheng RH, Zhang WW, Ji YN, Bai XJ, Yan CP, Wang J, Bai F, Zhao ZQ.
    Eur J Pharmacol; 2020 Sep 15; 883():173318. PubMed ID: 32621911
    [Abstract] [Full Text] [Related]

  • 18. Epidermal growth factor receptor transactivation is necessary for glucagon-like peptide-1 to protect PC12 cells from apoptosis.
    Kimura R, Okouchi M, Kato T, Imaeda K, Okayama N, Asai K, Joh T.
    Neuroendocrinology; 2013 Sep 15; 97(4):300-8. PubMed ID: 23147408
    [Abstract] [Full Text] [Related]

  • 19. Glucagon-like peptide-1 and candesartan additively improve glucolipotoxicity in pancreatic β-cells.
    Wang HW, Mizuta M, Saitoh Y, Noma K, Ueno H, Nakazato M.
    Metabolism; 2011 Aug 15; 60(8):1081-9. PubMed ID: 21255808
    [Abstract] [Full Text] [Related]

  • 20. DPP IV inhibitor suppresses STZ-induced islets injury dependent on activation of the IGFR/Akt/mTOR signaling pathways by GLP-1 in monkeys.
    Zhang Y, Chen Y, Cheng J, Guo Z, Lu Y, Tian B.
    Biochem Biophys Res Commun; 2015 Jan 02; 456(1):139-44. PubMed ID: 25446112
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.